Molecular Profiling of Advanced Soft-tissue Sarcomas

NCT03784014 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

603

Enrollment

OTHER_GOV

Sponsor class

Conditions

Soft Tissue Sarcoma

Interventions

DRUG: Nilotinib
DRUG: Ceritinib
DRUG: Capmatinib
DRUG: Lapatinib
DRUG: Trametinib
COMBINATION_PRODUCT: Trametinib and Dabrafenib
COMBINATION_PRODUCT: Olaparib and Durvalumab
DRUG: Palbociclib
DRUG: Glasdegib
DRUG: TAS-120
OTHER: Next Generation sequencing exome

Sponsor

Institut National de la Santé Et de la Recherche Médicale, France

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]